MoneyWorks4Me

Cipla informs about quarterly statement of investor complaints

21 Oct 2016 Evaluate

Cipla has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1749.20
Dr. Reddys Labs. 1232.90
Cipla 1330.50
Lupin 1964.50
Zydus Lifesciences 1121.75
View more..